SummerSimo Travel Troubles Notes and The Purring Page

According to a recent news article, researchers from the University of Oxford are working on developing a vaccine for a new virus with pandemic potential that could be ready in as little as 100 days. The researchers are examining how to adapt the vaccine they created for Covid-19 for an unknown disease, also known as Disease X. The Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Oxford scientists up to $80 million (£63.6 million) for the project. The CEPI said this would “pave the way for the development of new vaccines… within just 100 days of a virus with pandemic potential emerging”. Researchers will also be tasked with working on ways to speed up manufacture of jabs so vaccines could be rolled out more quickly in the event of a future outbreak.

In summary, researchers from the University of Oxford are working on developing a vaccine for an unknown disease, also known as Disease X, that could be ready in as little as 100 days. The Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Oxford scientists up to $80 million (£63.6 million) for the project. Researchers will also be tasked with working on ways to speed up manufacture of jabs so vaccines could be rolled out more quickly in the event of a future outbreak. The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that finances independent research projects to develop vaccines against emerging infectious diseases (EID). CEPI was officially launched in Davos in January 2017 as a global mechanism to explore and develop new ways to stimulate, finance and co-ordinate vaccine development against priority public health threats, in alignment with the WHO R&D Blueprint for action to prevent epidemics. CEPI takes donations from public, private, philanthropic, and civil society organisations. CEPI’s vision is for the world to be able to respond to the next Disease X with a new vaccine in 100 days. CEPI’s $3.5 billion plan outlines 5 areas of innovation needed to make delivery of pandemic vaccines within 100 days a reality.

The Coalition for Epidemic Preparedness Innovations (CEPI) focuses on developing vaccines against deadly diseases for which no licensed vaccines are currently available. CEPI’s priority diseases include the Middle East respiratory syndrome-related coronavirus (MERS-CoV), the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the Nipah virus, the Lassa fever virus, and the Rift Valley fever virus, as well as the Chikungunya virus and the hypothetical, unknown pathogen “Disease X”. CEPI has made investments in 21 vaccine candidates against its priority pathogens (Lassa, MERS, Rift Valley Fever, Nipah, Chikungunya and Ebola), 14 COVID-19 vaccines, 13 broadly protective coronavirus vaccines, and an array of enabling science projects. CEPI’s $3.5 billion plan outlines 5 areas of innovation needed to make delivery of pandemic vaccines within 100 days a reality.